GlassScriptPhysician profile
Junaid Ahmed
NPI 1376830109
$673.58
in general payments reported to CMS, 2019-2025
10 companies · $164 in 2025
The $164 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $63.14 · 2021: $145 · 2022: $126 · 2023: $176 · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $339.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $339.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $125.92 | 2022 | |
| Shockwave Medical, INC | $124.46 | 2025 | |
| Bard Peripheral Vascular, INC. | $121.95 | 2023 | |
| Avanir Pharmaceuticals, INC. | $114.96 | 2021 | |
| Boston Scientific Corporation | $53.78 | 2023 | |
| Cardiovascular Systems INC. | $43.44 | 2020 | |
| Abbott Laboratories | $40.31 | 2020-2025 | Cardiomems |
| Cycle Pharmaceuticals INC | $18.67 | 2025 | Venxxiva |
| Ge Healthcare | $15.21 | 2021 | |
| Novartis Pharmaceuticals Corporation | $14.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Junaid Ahmed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.